- Home
- AVIR vs FNLC Comparison
AVIR vs FNLC Comparison
Compare AVIR & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- FNLC
- Stock Information
- Founded
- AVIR 2012
- FNLC 1864
- Country
- AVIR United States
- FNLC United States
- Employees
- AVIR N/A
- FNLC N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- FNLC Major Banks
- Sector
- AVIR Health Care
- FNLC Finance
- Exchange
- AVIR Nasdaq
- FNLC Nasdaq
- Market Cap
- AVIR 277.8M
- FNLC 284.0M
- IPO Year
- AVIR 2020
- FNLC 1999
- Fundamental
- Price
- AVIR $3.50
- FNLC $25.83
- Analyst Decision
- AVIR Hold
- FNLC
- Analyst Count
- AVIR 1
- FNLC 0
- Target Price
- AVIR $6.00
- FNLC N/A
- AVG Volume (30 Days)
- AVIR 361.0K
- FNLC 17.6K
- Earning Date
- AVIR 08-07-2025
- FNLC 07-23-2025
- Dividend Yield
- AVIR N/A
- FNLC 5.73%
- EPS Growth
- AVIR N/A
- FNLC 13.09
- EPS
- AVIR N/A
- FNLC 2.68
- Revenue
- AVIR N/A
- FNLC $85,448,000.00
- Revenue This Year
- AVIR N/A
- FNLC N/A
- Revenue Next Year
- AVIR N/A
- FNLC N/A
- P/E Ratio
- AVIR N/A
- FNLC $9.64
- Revenue Growth
- AVIR N/A
- FNLC 10.86
- 52 Week Low
- AVIR $2.46
- FNLC $22.11
- 52 Week High
- AVIR $4.15
- FNLC $31.05
- Technical
- Relative Strength Index (RSI)
- AVIR 48.71
- FNLC 51.92
- Support Level
- AVIR $3.33
- FNLC $25.36
- Resistance Level
- AVIR $3.60
- FNLC $26.85
- Average True Range (ATR)
- AVIR 0.16
- FNLC 0.67
- MACD
- AVIR -0.02
- FNLC 0.07
- Stochastic Oscillator
- AVIR 26.69
- FNLC 56.60
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.